文献速递胸部肿瘤放疗

局限期小细胞肺癌每日一次与每日两次放疗的决策标准

Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise.
PubMed 文献 · Radiother Oncol · 2020-05-22

CONVERT试验未证实每日一次放疗(66 Gy)优于每日两次放疗(45 Gy)。专家间每日一次与每日两次方案的使用总体均衡,但体能好且能每日两次往返放疗中心的患者有倾向每日两次的趋势。

要点

  • 后勤因素、患者体能状态和放疗剂量限制是主要决策标准。
  • 每日一次与每日两次方案在欧洲专家间使用均衡。
  • 体能好且能每日两次往返者呈倾向每日两次的趋势。

核心结论

  • 每日两次与每日一次放疗均为专家接受的方案,决策受交通可及性等实际因素影响。

主要发现

  • 后勤原因、患者体能状态和放疗剂量限制是多数专家决策时使用的三大主要标准。
  • 每日一次与每日两次方案在欧洲专家间使用均衡,但体能好且能每日两次前往放疗中心的患者呈倾向每日两次的趋势。

关键数值与推荐

  • CONVERT试验未证实每日一次放疗(66 Gy)优于每日两次放疗(45 Gy)。

临床怎么用

  • 在局限期小细胞肺癌选择每日一次或每日两次放疗时,可结合后勤条件、患者体能状态和放疗剂量限制综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In limited disease small cell lung cancer (LD-SCLC), the CONVERT trial has not demonstrated superiority of once-daily (QD) radiotherapy (66 Gy) over twice-daily (BID) radiotherapy (45 Gy). We explored the factors influencing the selection between QD and BID regimens. METHODS: Thirteen experienced European thoracic radiation oncologists as selected by the European Society for Therapeutic Radiation Oncology (ESTRO) were asked to describe their strategies in the management of LD-SCLC. Treatment strategies were subsequently converted into decision trees and analysed for agreement and discrepancies. RESULTS: Logistic reasons, patients' performance status and radiotherapy dose constraints were the three major decision criteria used by most experts in decision making. The use of QD and BID regimens was balanced among European experts, but there was a trend towards the BID regimen for fit patients able to travel twice a day to the radiotherapy site. CONCLUSION: BID and QD radiotherapy are both accepted regimens among experts and the decision is influenced by pragmatic factors such as availability of transportation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Glatzer M, Faivre-Finn C, De Ruysscher D, et al. Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise. Radiother Oncol. 2020. PMID: 32447035. doi:10.1016/j.radonc.2020.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。